Although the concordance of TWEAK and Fn14 expression between CRLMs and matched primary tumors remains undetermined, our study identified upregulated TWEAK and Fn14 expression in CRLMs, which suggests that the TWEAK/Fn14 axis may serve as a therapeutic target in metastatic colorectal cancer. This evidence concerns the gene TNFSF12 and metastatic colorectal cancer.